hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

NCT00082758 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

NETWORK

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: hu14.18-Interleukin-2 fusion protein

Sponsor

Children's Oncology Group

Collaborators

[object Object]